L
Luana Di Murro
Researcher at University of Rome Tor Vergata
Publications - 14
Citations - 216
Luana Di Murro is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 6, co-authored 13 publications receiving 183 citations.
Papers
More filters
Journal ArticleDOI
Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities
Grazia Tortorelli,Luana Di Murro,Rosaria Barbarino,Sara Cicchetti,Daniela di Cristino,Maria Daniela Falco,Dahlia Fedele,Gianluca Ingrosso,Dania Janniello,Pasquale Morelli,Alessandra Murgia,Elisabetta Ponti,Sara Terenzi,Barbara Tolu,Riccardo Santoni +14 more
TL;DR: D dose inhomogeneity underneath G2 – G3 skin reactions seems to be the most important predictor for acute skin damage and in these patients more complex treatment techniques should be considered to avoid skin damage.
Journal ArticleDOI
Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience.
Gianluca Ingrosso,Fabio Trippa,Ernesto Maranzano,Alessandra Carosi,Elisabetta Ponti,Fabio Arcidiacono,L. Draghini,Luana Di Murro,Andrea Lancia,Riccardo Santoni +9 more
TL;DR: This study demonstrates that SBRT is safe, effective, and minimally invasive in the eradication of limited nodal metastases, yielding an important delay in prescribing ADT.
Journal ArticleDOI
Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience
Elisabetta Ponti,Gianluca Ingrosso,Alessandra Carosi,Luana Di Murro,Andrea Lancia,Franca Pietrasanta,Riccardo Santoni +6 more
TL;DR: SBRT seems to be safe, effective, and minimally invasive in the eradication of limited nodal recurrence from oligometastatic prostate cancer.
Journal ArticleDOI
Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis.
Andrea Lancia,Gianluca Ingrosso,Alessandra Carosi,Luana Di Murro,Emilia Giudice,Sara Cicchetti,Pasquale Morelli,Daniela di Cristino,Claudia Bruni,Alessandra Murgia,Alessandro Cancelli,Irene Turturici,Anjali Iadevaia,Elisabetta Ponti,Riccardo Santoni +14 more
TL;DR: A good performance status (KPS ≥80) seems to influence the clinical outcome of patients affected by a single isolated body metastasis treated with stereotactic body radiotherapy (SBRT), which is a safe, effective and minimally invasive treatment modality.
Journal ArticleDOI
Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
Gianluca Ingrosso,Roberto Miceli,Dahlia Fedele,Elisabetta Ponti,Michaela Benassi,Rosaria Barbarino,Luana Di Murro,Emilia Giudice,Federico Santarelli,Riccardo Santoni +9 more
TL;DR: Hypofractionated stereotactic radiotherapy have the significant limitation of uncertainty in interfraction repeatability of the patient setup; image-guided radiotherapy using cone-beam computed tomography improves the accuracy of the treatment delivery reducing set-up uncertainty, giving the possibility of 3-dimensional anatomic informations in the treatment position.